Current Protocols

  • An Interventional Study to Reduce Folate Levels in Men on Active Surveillance for Prostate Cancer - HSC20160340H
  • Computer Assisted Renal Volumetric Assessment to Predict Post Operative Renal Function Prior to Extirpative Surgery - HSC20150089H
  • Clinical Trial of Angiotensin Receptor Blocker in the Treatment of the Small Renal Mass: A Pilot Study - HSC20160585H
  • Prostate MRI as a Screening Tool to Detect Prostate Cancer - HSC20150160H
  • Rapid PCR to Guide Antibiotic Therapy at the Time of Prostate Biopsy - HSC20160386H
  • Repository for Bladder and Genitourinary Cancer
  • Multi-Institutional Study to Evaluate DNA Methylation Markers for Detection of Primary Bladder Cancers in Urine Samples from a Cohort of Patients with Hematuria
  • A Phase III, Open Label Study to Evaluate the Safety and Efficacy of INSTILADRIN┬« (rAd-IFN/Syn3) Administered Intravesically to Patients with High Grade, BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)
  • A Randomized study of rapamycin combined with intravesical BCG in patients with non-muscle invasive bladder cancer
  • Surveillance for low and low-intermediate risk non-muscle invasive bladder cancer: A Pilot Study
  • Impact of Yoga As Complementary Therapy on Quality of Life, Pro-inflammatory, and Cellular Immune Biomarkers in Patients Undergoing Radical Prostatectomy: A Pilot Randomized-Controlled Trial - 15-406H
  • Radical Cystectomy Compared with Chemoradiation for Muscle Invasive Bladder Cancer: A Pilot, Randomized-Controlled Non-Inferiority Trial - 15-620H
  • Clinical Evaluation of the ExoIntelliScore Prostate in men presenting for initial biopsy; additional confirmation study including impact on decision-making and heath economics. - 17-067Hb
  • The Role of miR21 in Patients Presenting to the Emergency Department with Acute Ureteral Stones - HSC20150840H